Latest revenue
$726.8K
as of 2022-12-31
Latest net income
$-240.3K
as of 2022-12-31
Net margin
-33.1%
as of 2022-12-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Services-Testing Laboratories (5 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.
Community sentiment
Where do you think FUNI is heading?
Price · 5Y
Market data
Price feed temporarily unavailable for FUNI.
5-year trend
What this company does
ITEM 1. BUSINESS Background Hypha Labs, Inc. was incorporated in Nevada on October 5, 2010. Hypha Labs, Inc. and its subsidiaries (“Hypha Labs,” the “Company,” “we,” “our” or “us”) was a service-oriented independent testing laboratory, data analytics and media firm focused on the developing cannabis and hemp markets, and supported the cannabis industry’s best practices for reliable testing. Our mission was to provide pharmaceutical-grade analysis and testing to the cannabis industry, under ISO-17025:2017 guidelines, to ensure consumers and patients know exactly what was in the cannabis they ingest and to help maximize the quality of our clients’ products through research, development, and…
AI summary unavailable — showing raw filing excerpt
Generated from FUNI's filing dated 2026-01-15
Key risks
Risk Factors The following important factors, and the important factors described elsewhere in this report or in our other filings with the Securities and Exchange Commission (“SEC”), could affect (and in some cases have affected) our results and could cause our results to be materially different from estimates or expectations. Other risks and uncertainties may also affect our results or operations adversely. The following and these other risks could materially and adversely affect our business, operations, results or financial condition. An investment in the Company is highly speculative in nature and involves an extremely high degree of risk. Risks Related To Our Businesses Our auditor…
AI summary unavailable — showing raw filing excerpt
Generated from FUNI's filing dated 2026-01-15
Profitability
Gross margin
39.5%
38.2%Operating margin
-42.6%
38.1%Net margin
-76.2%
177.9%Return on equity
127.3%
104.3%Return on assets
-758.0%
376.6%Leverage
Debt / equity
-1.17×
16.1%Long-term debt / equity
-0.18×
45.1%Debt / assets
695.5%
95.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-521.1K | +18.8% | — |
Q4 2025 2025-12-31 | — | — | $-521.6K | +61.1% | — |
Q3 2025 2025-09-30 | — | — | $-558.4K | +34.6% | — |
Q2 2025 2025-06-30 | — | — | $-562.0K | -75.9% | — |
Q1 2025 2025-03-31 | — | — | $-641.8K | -372.2% | — |
Q4 2024 2024-12-31 | — | — | $-1.3M | -983.4% | — |
Q3 2024 2024-09-30 | — | — | $-853.5K | — | — |
Q2 2024 2024-06-30 | — | — | $-319.4K | -2134.6% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Testing Laboratories · SIC 8734
Your notes
Keep private notes on FUNI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for FUNI in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns FUNI
No institutional holdings on file for FUNI yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once FUNI's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.